HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Dasgupta, S. Articles by Hogan, E. L. Search for Related Content PubMed PubMed Citation Articles by Dasgupta, S. Articles by Hogan, E. L. Social Bookmarking                      What's this?

Journal of Lipid Research, Vol. 43, 751-761, May 2002
Copyright © 2002 by Lipid Research, Inc.

3-O-acetyl-sphingosine-series myelin glycolipids

Somsankar Dasgupta^1,*, Steven B. Levery and Edward L. Hogan^*

^* Department of Neurology, Medical University of South Carolina, 96 Jonathan Lucas Street, P.O. Box 250606, Charleston, SC 29425
Complex Carbohydrate Research Center and Department of Biochemistry and Molecular Biology, University of Georgia, 220 Riverbend Road, Athens, GA 30602

¹ To whom correspondence should be addressed. e-mail: dasgupta{at}musc.edu

Several glycosphingolipids, less polar than galactosylceramide (GalCer), have been purified from rat brain and designated as fast migrating cerebrosides (FMCs). They co-appear with GalCer during myelinogenesis, reach a peak concentration at postnatal day 25–30 and are derivatives of GalCer. Extensive structural analysis of the partially methylated alditol acetates, mass-spectrometry, and ¹H- and ¹³C-nuclear magnetic resonance (NMR) spectroscopy unequivocally established the structure of two of these FMCs as 3-O-acetyl-sphingosine GalCer with non-hydroxy and hydroxy fatty N-acylation respectively. That is, an acetyl group is linked at the C3-OH of the sphingosine base of GalCer. In addition, NMR spectroscopy of all of the purified FMCs indicates that they contain a 3-O-acetyl group linked with sphingosine and thus delineates a novel series. Several lines of evidence indicate that FMCs are myelin constituents. FMCs, enriched in both central nervous system (CNS) and peripheral nervous system (PNS) myelin, are concentrated in spinal cord and white matter that are composed of myelinated nerve fibers. There is N-acylation with -hydroxy and C18 and C24 fatty acids, all characteristic of myelin components. They disappear along with GalCer in the murine genetic dysmyelinating disorders, jimpy and quaking, and in a knockout mutant which is devoid of GalCer. In addition, a decrease in FMC and GalCer concentration has been found in Krabbé's disease, a human genetic dysmyelinating disorder.—Dasgupta, S., S. B. Levery, and E. L. Hogan. 3-O-acetyl-sphingosine-series myelin glycolipids: characterization of novel 3-O-acetyl-sphingosine galactosylceramide. J. Lipid Res. 2002. 43: 751–761.

Abbreviations: dqCOSY, double quantum filtered correlation spectroscopy; ESI-MS, electrospray ionization mass spectrometry; FMC, fast migrating cerebroside; GalCer, Galß1-1Cer; GlcCer, Glcß1-1Cer; GM4, NeuAc2-3GalCer; GC-MS, gas chromatography mass spectrometry; GSL, glycosphingolipid; gHMBC, gradient heteronuclear multiple bond correlation; gHSQC, gradient heteronuclear single quantum correlation; HFA, hydroxy fatty acid; jp, jimpy; KO, knockout; NFA, non-hydroxy fatty acid; PMAA, partially methylated alditol acetate; qk, quaking; sulfatide, I³-sulfate GalCer; TMS, tetramethylsilane; TOCSY, total correlation spectroscopy

Supplementary key words dysmyelinating disorder • mass spectrometry • monoglycosylceramide • nuclear magnetic resonance spectroscopy • vertebrate brain

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				J. Bodennec, D. Pelled, and A. H. Futerman Aminopropyl solid phase extraction and 2 D TLC of neutral glycosphingolipids and neutral lysoglycosphingolipids J. Lipid Res., January 1, 2003; 44(1): 218 - 226. [Abstract] [Full Text] [PDF]